328 related articles for article (PubMed ID: 7013094)
1. Treatment of falciparum malaria with sulfalene-pyrimethamine versus sulfadoxine-pyrimethamine.
Chongsuphajaisiddhi T; Youngchaiyudha S; Rungpitarangsri V; Trishnananda M; Ruksakul T; Charnond L; Boonamrung S
Southeast Asian J Trop Med Public Health; 1980 Dec; 11(4):524-7. PubMed ID: 7013094
[TBL] [Abstract][Full Text] [Related]
2. Comparative drug trial of a sulfadoxine/pyrimethamine and a sulfalene/pyrimethamine combination against Plasmodium falciparum infections in semi-immune populations of Burma.
Tin F; Nyunt-Hlaing
Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):238-48. PubMed ID: 6239381
[TBL] [Abstract][Full Text] [Related]
3. Sulfadoxine-pyrimethamine resistant falciparum malaria in Thai children.
Chongsuphajaisiddhi T; Sabchareon A
Southeast Asian J Trop Med Public Health; 1981 Sep; 12(3):418-21. PubMed ID: 7043751
[TBL] [Abstract][Full Text] [Related]
4. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
[TBL] [Abstract][Full Text] [Related]
5. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
de Souza JM; Sheth UK; de Oliveira RM; Roulet H; de Souza SD
Bull World Health Organ; 1985; 63(3):603-9. PubMed ID: 3899397
[TBL] [Abstract][Full Text] [Related]
6. A combination of sulfamonomethoxine and pyrimethamine versus other drugs for the treatment of malaria.
Ebisawa I; Ohara H
Jpn J Exp Med; 1986 Oct; 56(5):213-9. PubMed ID: 3543442
[TBL] [Abstract][Full Text] [Related]
7. Clearance of falciparum parasitaemia with a single dose sulfadoxine-pyrimethamine in Vientiane, Laos.
Tawil NA
Southeast Asian J Trop Med Public Health; 1978 Sep; 9(3):409-13. PubMed ID: 373131
[TBL] [Abstract][Full Text] [Related]
8. The effect of sulphadoxine/pyrimethamine on gametocytes in falciparum malaria.
Ittiravivongs A; Vasuvat C; Kongrod S
Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):323-5. PubMed ID: 6395351
[TBL] [Abstract][Full Text] [Related]
9. The effect of mefloquine-sulfadoxine-pyrimethamine vs quinine on patients with complicated falciparum malaria.
Myint PT; Shwe T
Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):223-5. PubMed ID: 3313739
[TBL] [Abstract][Full Text] [Related]
10. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
Vleugels MP; Wetsteyn JC; Meuwissen JH
Trop Geogr Med; 1982; 34(3):263-5. PubMed ID: 6758246
[TBL] [Abstract][Full Text] [Related]
11. Response of falciparum malaria to chloroquine and three second line antimalarial drugs in a Kenyan coastal school age population.
Hagos B; Khan B; Ofulla AV; Kariuki D; Martin SK
East Afr Med J; 1993 Oct; 70(10):620-3. PubMed ID: 8187656
[TBL] [Abstract][Full Text] [Related]
12. Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.
Tin F; Hlaing N; Tun T; Win S; Lasserre R
Bull World Health Organ; 1985; 63(4):727-30. PubMed ID: 2935320
[TBL] [Abstract][Full Text] [Related]
13. Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand.
Hurwitz ES; Johnson D; Campbell CC
Lancet; 1981 May; 1(8229):1068-70. PubMed ID: 6112445
[TBL] [Abstract][Full Text] [Related]
14. Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
Boudreau EF; Pang LW; Chaikummao S; Witayarut C
Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):183-9. PubMed ID: 1948277
[TBL] [Abstract][Full Text] [Related]
15. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH
Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
[TBL] [Abstract][Full Text] [Related]
16. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ
Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy study of combination fansidar-sulphate quinine and fansidar-HCl tetracycline in falciparum malaria in children above 7 years old.
Silitonga K; Rampengan TH
Paediatr Indones; 1991; 31(3-4):111-6. PubMed ID: 1956689
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru.
Marquiño W; Ylquimiche L; Hermenegildo Y; Palacios AM; Falconí E; Cabezas C; Arróspide N; Gutierrez S; Ruebush TK
Am J Trop Med Hyg; 2005 May; 72(5):568-72. PubMed ID: 15891131
[TBL] [Abstract][Full Text] [Related]
19. [Malaria in pregnant women--native inhabitants of the Congo--and its treatment using quinimax and fansidar].
Splavskiĭ OI
Med Parazitol (Mosk); 1986; (5):49-51. PubMed ID: 3540557
[No Abstract] [Full Text] [Related]
20. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
